Hemogenyx Pharmaceuticals Receives FDA Approval to Proceed with HEMO-CAR-T Clinical Trials for Acute Myeloid Leukemia

Name: Hemogenyx Pharmaceuticals Receives FDA Approval to Proceed with HEMO-CAR-T Clinical Trials for Acute Myeloid Leukemia
Uploaded: 2024-02-09T13:41:14.966345+00:00
Duration: 72 s
Channel: Vox Markets
Description: Hemogenyx Pharmaceuticals Receives FDA Approval to Proceed with HEMO-CAR-T Clinical Trials for Acute Myeloid Leukemia

2 views

2 years ago